Psychiatr. pro Praxi, 2008; 9(2): 84-85

Antipsychotika versus režimové faktory: vliv na hmotnost hospitalizovaných pacientů

MUDr. Martin Hýža1, MUDr. Vlasta Hanušková1, MUDr. Svatopluk Sedláček2, RNDr. Jiří Létal Ph.D3
1 Psychiatrická léčebna Opava
2 Psychiatrická léčebna, Opava
3 Institut biostatistiky a analýz, MU, Brno

Práce sledovala změny BMI, glykemie a lipidogramu u pacientů hospitalizovaných v Psychiatrické léčebně v Opavě po dobu 6 týdnů od přijetí. Aktivní skupinu tvořili pacienti užívající D2/D3-antagonisty, olanzapin nebo quetiapin, kontrolní skupinu pacienti bez medikace (z oddělení pro léčbu závislostí). Zjistili jsme významný rozdíl v nárůstu hmotnosti v závislosti na podávané medikaci. Průkazný vliv medikace na zvýšení hmotnosti byl pouze u olanzapinu, protože i pacienti bez medikace vykazovali průměrný relativní přírůstek BMI 1,8 %. U laboratorních parametrů nedošlo ke statisticky významné změně oproti výchozím hodnotám.

Published: April 15, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hýža M, Hanušková V, Sedláček S, Létal J. Antipsychotika versus režimové faktory: vliv na hmotnost hospitalizovaných pacientů. Psychiatr. praxi. 2008;9(2):84-85.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Allison DB, Mentore JL, Heo M et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686-1696. Go to original source... Go to PubMed...
    2. Ascher-Svanum H, Stensland MD, Kinon BJ, Tollefson GD. Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic. J Psychopharmacol 2005; 19(6 Suppl): 110-117. Go to original source... Go to PubMed...
    3. Kinon BJ, Kaiser CJ, Ahmed S, Rotelli MD, Kollack-Walker S. Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders. J Clin Psychopharmacol 2005; 25(3): 255-258. Go to original source... Go to PubMed...
    4. Leslie DL, Rosenheck RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medication. Am J Psychiatry 2004; 161: 1709-1711. Go to original source... Go to PubMed...
    5. Marder SR, McQuade RD, Stock E, et al. Aripiprazole in the treatment of schizophrenia: Safety and tolerability in short-term, placebo-controlled trials. Schizophr Res. 2003; 61: 123-136. Go to original source... Go to PubMed...
    6. Raboch J, Anders M, Praško J, Hellerová P (ed.). Doporučené postupy psychiatrické péče II. Infopharm, Praha 2006.
    7. Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC. The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 2002; 63: 856-865. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.